Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Budget improvement comes from insight into everyday spending. Monitor, categorize, and adjust habits to maximize savings and achieve financial targets.
25,649 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Tesla stock has dipped below $400 again, prompting questions about a potential buy. This guide weighs growth drivers ...
Polestar stock plunged 29% in a single week. There was no obvious single news trigger, but a mix of market forces and...
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
The U.S. retirement system gets c-plus in key metrics, prompting policymakers to push overdue reforms. This report ex...
Palantir’s CEO has shifted away from traditional earnings calls, instead sending quarterly shareholder letters that m...
Tuesday brought a notable rally in Honeywell shares as the company outlined a stand-alone path for Quantinuum. This a...
Is Byrna Technologies the next big opportunity in non-lethal protection? This analysis breaks down the growth case, k...
When memory stocks surged on AI demand, one bold strategic move stood out. This article explains how micron just elim...
A quiet giant in the chip world could deliver a rare investment upside. This guide explains what makes taiwan semicon...
When software stocks dip, smart investors look for durable moats, growing cash flow, and AI-enabled growth. This guid...
Alphatec (ATEC) is navigating a shifting spine device market. This guide breaks down expected 2025 earnings, key driv...